{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:57:35Z","timestamp":1792601855746,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.biomaterials.2010.10.049","type":"journal-article","created":{"date-parts":[[2010,11,17]],"date-time":"2010-11-17T04:20:34Z","timestamp":1289967634000},"page":"1669-1677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Efficacy of engineered FVIII-producing skeletal muscle enhanced by growth factor-releasing co-axial electrospun fibers"],"prefix":"10.1016","volume":"32","author":[{"given":"I-Chien","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kam W.","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.biomaterials.2010.10.049_bib1","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1172\/JCI10376","article-title":"Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective?","volume":"105","author":"Cossu","year":"2000","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.biomaterials.2010.10.049_bib2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.molmed.2007.12.004","article-title":"The emerging biology of satellite cells and their therapeutic potential","volume":"14","author":"Kuang","year":"2008","journal-title":"Trends Mol Med"},{"issue":"4","key":"10.1016\/j.biomaterials.2010.10.049_bib3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.pmr.2005.08.020","article-title":"Cell therapy for muscle regeneration and repair","volume":"16","author":"Cao","year":"2005","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"8","key":"10.1016\/j.biomaterials.2010.10.049_bib4","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/sj.gt.3300687","article-title":"Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts","volume":"5","author":"Regulier","year":"1998","journal-title":"Gene Ther"},{"issue":"1","key":"10.1016\/j.biomaterials.2010.10.049_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1620001","article-title":"Using skeletal muscle as an artificial endocrine tissue","volume":"162","author":"MacColl","year":"1999","journal-title":"J Endocrinol"},{"issue":"1","key":"10.1016\/j.biomaterials.2010.10.049_bib6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/excr.2002.5562","article-title":"Properties of primary mouse myoblasts expanded in culture","volume":"278","author":"Lorenzon","year":"2002","journal-title":"Exp Cell Res"},{"issue":"2","key":"10.1016\/j.biomaterials.2010.10.049_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/sj.gt.3301874","article-title":"Non-viral gene delivery in skeletal muscle: a protein factory","volume":"10","author":"Lu","year":"2003","journal-title":"Gene Ther"},{"key":"10.1016\/j.biomaterials.2010.10.049_bib8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1021\/nl060060o","article-title":"Myotube assembly on nanofibrous and micropatterned polymers","volume":"6","author":"Huang","year":"2006","journal-title":"Nano Lett"},{"key":"10.1016\/j.biomaterials.2010.10.049_bib9","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1083\/jcb.200405004","article-title":"Myotube differentiate optimally on substrates with tissue-like stiffness: pathological implications for soft or stiff microenvironments","volume":"166","author":"Engler","year":"2004","journal-title":"J Cell Biol"},{"key":"10.1016\/j.biomaterials.2010.10.049_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12195-008-0021-y","article-title":"Effect of electromechanical stimulation on the maturation of myotubes on aligned electrospun fibers","volume":"1","author":"Liao","year":"2008","journal-title":"Cell Mol Bioeng"},{"key":"10.1016\/j.biomaterials.2010.10.049_bib11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/jcp.20936","article-title":"Cytoskeleton\/stretch-activated ion channel interaction regulates myogenic differentiation of skeletal myoblasts","volume":"211","author":"Formigli","year":"2007","journal-title":"J Cell Physiol"},{"issue":"1","key":"10.1016\/j.biomaterials.2010.10.049_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2009.06.007","article-title":"Sustained viral gene delivery through core-shell fibers","volume":"139","author":"Liao","year":"2009","journal-title":"J Control Release"},{"issue":"4","key":"10.1016\/j.biomaterials.2010.10.049_bib13","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2217\/17435889.1.4.465","article-title":"Aligned core-shell nanofibers delivering bioactive proteins","volume":"1","author":"Liao","year":"2006","journal-title":"Nanomedicine"},{"issue":"5","key":"10.1016\/j.biomaterials.2010.10.049_bib14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2141.2007.06942.x","article-title":"Gene therapy for haemophilia","volume":"140","author":"Murphy","year":"2008","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.biomaterials.2010.10.049_bib15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00062752-200211000-00008","article-title":"Gene therapy for bleeding disorders","volume":"9","author":"Manno","year":"2002","journal-title":"Curr Opin Hematol"},{"issue":"3","key":"10.1016\/j.biomaterials.2010.10.049_bib16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jconrel.2008.06.019","article-title":"Gene transfer to hemophilia A mice via oral delivery of FVIII-chitosan nanoparticles","volume":"132","author":"Bowman","year":"2008","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.biomaterials.2010.10.049_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399406010337","article-title":"RNA repair for haemophilia A","volume":"8","author":"Chao","year":"2006","journal-title":"Expert Rev Mol Med"},{"issue":"8","key":"10.1016\/j.biomaterials.2010.10.049_bib18","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nm900","article-title":"Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing","volume":"9","author":"Chao","year":"2003","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.biomaterials.2010.10.049_bib19","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/jgm.683","article-title":"FVIII gene delivery by muscle electroporation corrects murine hemophilia A","volume":"7","author":"Long","year":"2005","journal-title":"J Gene Med"},{"issue":"6","key":"10.1016\/j.biomaterials.2010.10.049_bib20","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2003-01-0167","article-title":"Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion","volume":"102","author":"Powell","year":"2003","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.biomaterials.2010.10.049_bib21","doi-asserted-by":"crossref","first-page":"9973","DOI":"10.1073\/pnas.96.18.9973","article-title":"Gene therapy for the hemophilias","volume":"96","author":"Kay","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"10.1016\/j.biomaterials.2010.10.049_bib22","doi-asserted-by":"crossref","first-page":"11854","DOI":"10.1073\/pnas.182412299","article-title":"Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy","volume":"99","author":"Gao","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.biomaterials.2010.10.049_bib23","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1182\/blood-2008-07-167510","article-title":"AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells","volume":"114","author":"Mingozzi","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.biomaterials.2010.10.049_bib24","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1073\/pnas.0812090106","article-title":"Phenotypic correction of murine hemophilia A using an iPS cell-based therapy","volume":"106","author":"Xu","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"10.1016\/j.biomaterials.2010.10.049_bib25","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1056\/NEJM200106073442301","article-title":"Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A","volume":"344","author":"Roth","year":"2001","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.biomaterials.2010.10.049_bib26","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/jgm.1098","article-title":"Encapsulated human primary myoblasts deliver functional hFIX in hemophilic mice","volume":"9","author":"Wen","year":"2007","journal-title":"J Gene Med"},{"key":"10.1016\/j.biomaterials.2010.10.049_bib27","first-page":"935","article-title":"Transplanted endothelial cells repopulate the liver endothelium and correct the phenotype of hemophilia A mice","volume":"118","author":"Follenzi","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.biomaterials.2010.10.049_bib28","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1634\/stemcells.2006-0699","article-title":"Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo Factor VIII expression from lentivirally engineered endothelial progenitors","volume":"25","author":"Matsui","year":"2007","journal-title":"Stem Cells"},{"issue":"3","key":"10.1016\/j.biomaterials.2010.10.049_bib29","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ymthe.2006.03.019","article-title":"Angiogenesis enhances factor IX delivery and persistence from retrievable human bioengineered muscle implants","volume":"14","author":"Thorrez","year":"2006","journal-title":"Mol Ther"},{"issue":"12","key":"10.1016\/j.biomaterials.2010.10.049_bib30","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1096\/fj.02-0401fje","article-title":"Therapeutic lymphangiogenesis with human recombinant VEGF-C","volume":"16","author":"Szuba","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.biomaterials.2010.10.049_bib31","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/nbt1101-1029","article-title":"Polymeric system for dual growth factor delivery","volume":"19","author":"Richardson","year":"2001","journal-title":"Nat Biotechnol"},{"issue":"3","key":"10.1016\/j.biomaterials.2010.10.049_bib32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2141.2004.05291.x","article-title":"The crucial role of vascular permeability factor\/vascular endothelial growth factor in angiogenesis: a historical review","volume":"128","author":"Ribatti","year":"2005","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.biomaterials.2010.10.049_bib33","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1161\/CIRCRESAHA.108.182287","volume":"103","author":"Korpisalo","year":"2008","journal-title":"Circ Res"},{"issue":"20","key":"10.1016\/j.biomaterials.2010.10.049_bib34","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1182\/blood-2009-05-220327","article-title":"Recombinant canine B-domain-deleted FVIII exhibits high specific activity and is safe in the canine hemophilia A model","volume":"114","author":"Sabatino","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2010.10.049_bib35","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nbt1109","article-title":"Engineered vascularized skeletal muscle tissue","volume":"23","author":"Levenberg","year":"2005","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.biomaterials.2010.10.049_bib36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jpedsurg.2004.10.019","article-title":"Abdominal wall repair using a biodegradable scaffold seeded with cells","volume":"40","author":"Drewa","year":"2005","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.biomaterials.2010.10.049_bib37","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/hc3101.092215","article-title":"Recombinant vascular endothelial growth factor secreted from tissue-engineered bioartificial muscles promotes localized angiogenesis","volume":"104","author":"Lu","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.biomaterials.2010.10.049_bib38","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1073\/pnas.0903875106","article-title":"Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors","volume":"107","author":"Borselli","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2010.10.049_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(01)00150-8","article-title":"The physiology of the lymphatic system","volume":"50","author":"Swartz","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.biomaterials.2010.10.049_bib40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/(SICI)1520-6017(200003)89:3<297::AID-JPS2>3.0.CO;2-P","article-title":"Lymphatic transport of proteins after subcutaneous administration","volume":"89","author":"Porter","year":"2000","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.biomaterials.2010.10.049_bib41","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0049-3848(08)70002-1","article-title":"Role vWF immunogenicity FVIII","volume":"122","author":"Lacroix-Desmazes","year":"2008","journal-title":"Thromb Res"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961210013566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961210013566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:27:17Z","timestamp":1758900437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961210013566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0142961210013566"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2010.10.049","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of engineered FVIII-producing skeletal muscle enhanced by growth factor-releasing co-axial electrospun fibers","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2010.10.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}